These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15993579)

  • 1. Molecular changes in prostatic cancer.
    Bott SR; Arya M; Shergill IS; Williamson M
    Surg Oncol; 2005 Aug; 14(2):91-104. PubMed ID: 15993579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers and determinants of prostate cancer metastasis.
    Gopalkrishnan RV; Kang DC; Fisher PB
    J Cell Physiol; 2001 Dec; 189(3):245-56. PubMed ID: 11748582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular alterations in prostate cancer.
    Reynolds MA
    Cancer Lett; 2008 Nov; 271(1):13-24. PubMed ID: 18554779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Markers for diagnosis, prediction and prognosis of prostate cancer].
    Taskén KA; Angelsen A; Svindland A; Eide T; Berge V; Wahlquist R; Karlsen S
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3279-82. PubMed ID: 16327854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of determining the aggressiveness of prostate cancer using serum and tissue molecular markers.
    Kehinde EO; Maghrebi MA; Anim JT
    Can J Urol; 2008 Apr; 15(2):3967-74. PubMed ID: 18405443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.
    Tamura K; Furihata M; Tsunoda T; Ashida S; Takata R; Obara W; Yoshioka H; Daigo Y; Nasu Y; Kumon H; Konaka H; Namiki M; Tozawa K; Kohri K; Tanji N; Yokoyama M; Shimazui T; Akaza H; Mizutani Y; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
    Cancer Res; 2007 Jun; 67(11):5117-25. PubMed ID: 17545589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular markers in the diagnosis of prostate cancer.
    van der Poel HG
    Crit Rev Oncol Hematol; 2007 Feb; 61(2):104-39. PubMed ID: 16945550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood biomarkers for prostate cancer detection and prognosis.
    Shariat SF; Karam JA; Roehrborn CG
    Future Oncol; 2007 Aug; 3(4):449-61. PubMed ID: 17661720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of prostate cancer: clinical translational opportunities.
    Vecchione A; Gottardo F; Gomella LG; Wildemore B; Fassan Ms; Bragantini E; Pagano F; Baffa R
    J Exp Clin Cancer Res; 2007 Mar; 26(1):25-37. PubMed ID: 17550130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited genotype and prostate cancer outcomes.
    Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):945-52. PubMed ID: 12376492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer.
    Nanni S; Priolo C; Grasselli A; D'Eletto M; Merola R; Moretti F; Gallucci M; De Carli P; Sentinelli S; Cianciulli AM; Mottolese M; Carlini P; Arcelli D; Helmer-Citterich M; Gaetano C; Loda M; Pontecorvi A; Bacchetti S; Sacchi A; Farsetti A
    Mol Cancer Res; 2006 Feb; 4(2):79-92. PubMed ID: 16513839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of prostate cancer.
    Karayi MK; Markham AF
    Prostate Cancer Prostatic Dis; 2004; 7(1):6-20. PubMed ID: 14999233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology of prostate-cancer pathogenesis.
    Shand RL; Gelmann EP
    Curr Opin Urol; 2006 May; 16(3):123-31. PubMed ID: 16679847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature.
    Lapointe J; Malhotra S; Higgins JP; Bair E; Thompson M; Salari K; Giacomini CP; Ferrari M; Montgomery K; Tibshirani R; van de Rijn M; Brooks JD; Pollack JR
    Am J Surg Pathol; 2008 Feb; 32(2):205-9. PubMed ID: 18223322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic approaches to outcome prediction in prostate cancer.
    Febbo PG
    Cancer; 2009 Jul; 115(13 Suppl):3046-57. PubMed ID: 19544546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients.
    Orr-Urtreger A; Bar-Shira A; Bercovich D; Matarasso N; Rozovsky U; Rosner S; Soloviov S; Rennert G; Kadouri L; Hubert A; Rennert H; Matzkin H
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):474-9. PubMed ID: 16537704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
    Reyes I; Tiwari R; Geliebter J; Reyes N
    Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetics of prostate cancer].
    Thomas F; Jaïs P; Cohen-Akenine A
    Bull Cancer; 2001 Mar; 88(3):287-94. PubMed ID: 11313206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetics and molecular genetics of cancer of the prostate.
    Brothman AR
    Am J Med Genet; 2002 Oct; 115(3):150-6. PubMed ID: 12407695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.